Efficacy of empagliflozin in heart failure with preserved ejection fraction according to frailty status in EMPEROR‐Preserved

• मुख्य लेखकों: Andrew J.S. Coats (लेखक), Javed Butler (लेखक), Hiroyuki Tsutsui (लेखक), Wolfram Doehner (लेखक), Gerasimos Filippatos (लेखक), João Pedro Ferreira (लेखक), Michael Böhm (लेखक), Vijay K. Chopra (लेखक), Subodh Verma (लेखक), Matias Nordaby (लेखक), Tomoko Iwata (लेखक), Daisuke Nitta (लेखक), Piotr Ponikowski (लेखक), Faiez Zannad (लेखक), Milton Packer (लेखक), Stefan D. Anker (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Wiley, 2024-02-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Frailty is a severe, common co‐morbidity associated with heart failure (HF) with preserved ejection fraction (HFpEF). The impact of frailty on HFpEF outcomes may affect treatment choices in HFpEF. The impact of frailty on HFpEF patients and any impact on the clinical benefits of...